ADDvise Group AB’s (publ) subsidiary Germa has signed an agreement to sell a production unit owned by Germa. The Stockholm based company OXO Förvaltning AB is buying the property. In connection to the sale, Germa will sign a 10-year lease agreement with OXO Förvaltning. The purchase price is 4,75 MSEK.
Since the property is not leveraged, the sale directly improves the liquidity by 4,75 MSEK. The sale creates a profit of approximately 4,5 MSEK within the subsidiary Germa.
OXO Förvaltning will gain admittance to the property on January 12th, 2018.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
[email protected]
Important information:
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 9th, 2018 at 15 :15 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com .
Powered by WPeMatico
